On 19 February 2021, Bayer Agriculture BV, based in Belgium, submitted an application on behalf of Bayer CropScience LP, based in the United States, to the Commission, in accordance with Article 9(2) of Regulation (EC) No 1829/2003, for modification of the terms of the authorisation granted by Implementing Decision (EU) 2015/701, regarding the placing on the market of isolated seed protein produced from genetically modified oilseed rape GT73 for food.
Recital 3, Decision_act (EU) 2024/388
In forcesince 26 Jan 2024
Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 Septemb…9Law
- celex=32015D0701
- num:eu=2015/701